Literature DB >> 3265643

Buprenorphine abuse among opiate addicts.

J J O'Connor, E Moloney, R Travers, A Campbell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265643     DOI: 10.1111/j.1360-0443.1988.tb00536.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


× No keyword cloud information.
  18 in total

1.  Abuse of buprenorphine (Temgesic) by snorting.

Authors:  J Strang
Journal:  BMJ       Date:  1991-04-20

2.  Opioid substitution therapy for dependent health care practitioners: approach with caution.

Authors:  Paul H Earley
Journal:  Mayo Clin Proc       Date:  2012-08       Impact factor: 7.616

3.  Intravenous use of slow release morphine sulphate tablets.

Authors:  R N Bloor; N J Smalldridge
Journal:  BMJ       Date:  1990-03-10

Review 4.  Update on the clinical use of buprenorphine: in opioid-related disorders.

Authors:  Simon Ducharme; Ronald Fraser; Kathryn Gill
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

5.  Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.

Authors:  Sandra D Comer; Eric D Collins
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

6.  Pattern of buprenorphine abuse among opioid abusers in Nepal.

Authors:  Tapas Kumar Aich; Manoj Dhungana; Roshija Khanal
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

7.  Buprenorphine withdrawal syndrome.

Authors:  B M Tripathi; P Hemaraj; N K Dhar
Journal:  Indian J Psychiatry       Date:  1995-01       Impact factor: 1.759

8.  Buprenorphine abuse in India : an update.

Authors:  Y Sharma; S K Mattoo
Journal:  Indian J Psychiatry       Date:  1999-04       Impact factor: 1.759

9.  Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics.

Authors:  A E Eggen; M Andrew
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 10.  Practical considerations for the clinical use of buprenorphine.

Authors:  Hendree E Jones
Journal:  Sci Pract Perspect       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.